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Abstract- The preparation of t-butoxycarbonyl (Boc)-protected O4-(o-nitrophenyl) thymine peptide 
nucleic acid (PNA) monomer is described. This PNA monomer was incorporated into PNA oligomer 
sequences. The post-synthetic modification of the oligomers to yield fluorescently-labelled PNA 
oligomers was studied before and after the removal of the protecting groups. In both cases, the desired 
fluorescently-labelled PNA oligomer was obtained in good yields.  
 
 
Peptide nucleic acids (PNA) are oligonucleotide analogues in which the negatively 
charged sugar-phosphate backbone has been replaced by a neutral backbone of N-(2-
aminoethyl)glycine units with the common nucleic acid bases attached via a carbonyl 
methylene linker1. PNA oligomers recognize and bind to a specific DNA or RNA strand 
with high affinity and selectivity2. Their chemical stability and their resistance to 
nucleases and proteases make PNA oligomers good candidates as therapeutic agents, 
diagnostic tools and probes in molecular biology. For most of these applications the 
functionalisation and labelling of PNA are necessary3. 
 
Labelled PNA can be prepared by modification of the N-terminal amino group4,5. This 
is the most common approach but the reactive amino group can only be used for the 
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introduction of one modification. Also trifunctional amino acids such as cysteine or 
lysine or nucleobases carrying hexylamino groups have been introduced at various 
positions on the PNA oligomers to generate amino or thiol groups, which were further 
reacted with fluorescent labels6-8. Moreover, the introduction of labels by using 
modified PNA monomers has been described9-10. This method requires the previous 
synthesis of one monomer for each label. To avoid the need to synthesise a large 
number of different monomers, the reaction of fluorescent compounds to amino groups 
after the assembly of the oligomer was preferred6-8. In the present report we describe the 
synthesis of a novel PNA monomer (TNP, scheme 1) carrying an o-nitrophenyl group at 
position 4 of thymine. This group reacts with amines to generate 5-methyl-C derivatives 
(scheme 2). When this reaction is performed with fluorescent compounds carrying 
amino groups, PNA oligomers bearing fluorescent compounds may be obtained. 
Previously, this post-synthetic method was assayed together with PNA monomers 
carrying base-labile protecting groups11. Unfortunately, the conditions used during the 
labelling reaction and removal of protecting groups  (aqueous solutions of amines at 50 
ºC) were detrimental to the PNA integrity11. To avoid this problem we used t-
butoxycarbonyl (Boc)-protected PNA monomers carrying acid-labile 
(benzyloxycarbonyl, Z) protecting groups for the nucleobases. The use of acid 
conditions for the removal of the protecting groups allows the isolation of the PNA-
carrying TNP. In this way the labelling reaction can be performed in both solid-phase 
and solution. 
 
The preparation of PNA-monomers requires several steps to generate the properly 
protected N-(2-aminoethyl)glycine unit followed by N-acylation of the glycine 
derivative by a carboxymethylated nucleobase12-13. We followed this strategy to 
synthesise N-[2-(t-butoxycarbonylamino)-ethyl]-N-[(O4-o-nitrophenylthymin-1-yl) 
acetyl] glycine (TNP, scheme 1). The N-(2-aminoethyl)glycine unit was synthesized as 
the Boc-protected cyanoethyl ester derivative14. 1-Carboxymethyl-O4–(o-nitrophenyl) 
thymine was synthesized as described elsewhere11,15. Coupling of the two compounds 
was performed with N-[(dimethylamino)-1H, 1,2,3-triazolo-[4,5-b]pyridin-1-yl-
methylene]-N-methylmethanaminium hexafluorophosphate N-oxide (HATU) (1 eq.) 
and N,N-diisopropyl-N-ethylamine (DIEA) (2 eq.). The choice of the cyanoethyl ester 
instead of a methyl or ethyl ester was to avoid saponification that could provoke 
hydrolysis of the o-nitrophenyl group by nucleophilic attack, giving the undesired T-
PNA monomer. To obtain the carboxylic acid, cyanoethyl ester was removed by β-
elimination with a strong and non-nucleophilic base, 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU). In the presence of 0.5 M DBU in acetonitrile for 5 minutes at room 
temperature, loss of the nitrophenyl group was not detected. After silica-gel purification 
PNA monomer (TNP) was isolated as triethylammonium salt in 70% yield . 
PNA oligomer synthesis was carried out manually on a methylbenzhydrylamine 
(MBHA)-polystyrene support, following the synthesis cycle for the Boc/Z strategy 
described elsewhere16. The coupling efficiency of PNA monomer (TNP) was similar to 
that of the natural bases obtained from commercial sources (Applied Biosystems). 
Coupling reaction was monitorized by the Kaiser test17, and the absence of colour in the 
solution or resin beads indicated nearly quantitative yields (> 95%). 
 
Three PNA oligomer sequences containing monomer (TNP) were synthesised: A) Ac-
TNPTC AAC TCT-NH2, and B) Ac-TNP GTG CTC ATG GTG-NH2. During the 
assembly of sequences A and B, aliquots of the solid support were taken before and 
after the addition of TNP monomer. They were deprotected, cleaved, and analysed by 
reverse-phase HPLC (RP-HPLC). In both cases, the addition of TNP monomer was 
clearly observed by the formation of a new compound with a higher retention time, 
which had the expected molecular mass (Table 1). The hydrophobicity of the o-
nitrophenyl group facilitated the purification of the full-length product.  
 
The post-synthetic modification of PNA in solid-phase was studied on sequence A: 10 
mg of resin was treated with 75μl of a solution 0.2 M of Dansyl cadaverine (5-
dimethylaminonaphthalene–1-(N-(5-aminopentyl))sulfonamide, Molecular Probes Inc.) 
in N-methylpyrrolidone. After overnight incubation at 55oC, the fluorescent solution 
was filtered and the resin was washed until no fluorescence was detected. The product 
was deprotected and cleaved from the resin under standard protocols. The crude was 
desalted by a sephadex column (NAP-10) and then analysed and purified by RP-HPLC. 
The HPLC analysis revealed a major peak which was collected. The product was 
fluorescent and it had the expected mass, as judged by MALDI-TOF mass spectrometry 
(Table 1).  
 
The post-synthetic modification of PNA in solution was studied on sequence B. First, 
supports carrying PNA sequence B was treated with a mixture of trifluoroacetic acid 
and trifluoromethanesulfonic acid (using dimethylsulfide and m-cresol as scavengers) as 
described16. The resulting product was purified by RP-HPLC obtaining the desired PNA 
oligomer carrying TNP (Table 1). Aliquots of 0.1 mg were treated with dansyl 
cadaverine or with fluorescein cadaverine [5-(5-aminopentyl)thioureidyl]fluorescein 
dihydrobromide salt, Molecular Probes Inc.). In both cases a solution of the amine 
(10mM) in dimethylformamide containing 1% of DIEA was added to sequence B and 
allowed to react overnight at 55oC. After the treatment, the resulting solutions were 
concentrated to dryness and desalted with a Sephadex G-25 column (NAP-10). The 
labelled PNA containing fractions were analysed and purified by RP-HPLC (Table 1). 
Mass spectrometry confirmed that the desired product corresponded to the major peak 
on the chromatogram. In both cases, the conversion to the desired compound, estimated 
by comparison of the areas under the peaks, was higher than 70%. 
In conclusion, we have shown that PNA monomer (TNP) is a valuable intermediate for 
the introduction of fluorescent compounds or other compounds of interest in PNA 
oligomers, by nucleophilic displacement of the appropriate amino derivative. This 
method may be used to prepare several derivatives from the same PNA sequence. Also, 
this method may be used in combination of others4-10 to introduce multiple labels into 
the same compound. For example, when monomer (TNP) is placed at any position, the 
amino terminal group is still free to react with a second label. The introduction of two 
different fluorescent labels in PNA is of interest for the preparation of molecular 
beacons8,18 for diagnosis and biomedical studies. Although PNA monomer (TNP) was 
incorporated at the N-terminal position it may be introduced at any position on the PNA 
oligomer as shown elsewhere.11  
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Table 1: PNA oligomers prepared in this work. 
 
Sequence1 (N->C) RT (min)2 Mass, Found Mass, Calcd. 
TCAACTCT 11.8 2120.5 2119 
A) Ac-TNPTCAACTCT 19.4 2549.0 2506 
Ac-MDCTCAACTCT 18.9 2745.7 2746 
GTGCTCATGGTG 13.8 3316.4 3315 
B) Ac-TNPGTGCTCATGGTG 19.5 3746.5 3745 
Ac-MDCGTGCTCATGGTG 19.1 3943.1 3942 
Ac-MFCGTGCTCATGGTG 22.0 4097.9 4098 
 
1TNP= O4-o-nitrophenylthymine, MDC= 5-methylcytosine carrying dansylcadaverine 
(DC), MFC= 5-methylcytosine carrying fluoresceinecadaverine (FC) 
2HPLC conditions. Column: Nucleosil 120 C18, (250x8 mm), flow rate 3 ml/min, a 25 
min gradient from 0% B to 50% B. Solution A: 5% acetonitrile in 0.1% trifluoroacetic 
acid in water. Solution B: 70% acetonitrile in 0.1% trifluoroacetic acid in water.  
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